Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03361020 : Obstructive Sleep Apnea in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation
Phase
AgesMin: 18 Years Max: N/A
Eligibility
HODGKIN LYMPHOMA SURVIVOR ELIGIBILITY CRITERIA

Inclusion Criteria (Hodgkin Lymphoma Survivor):

- Current participant in the SJLIFE clinical trial ongoing at St. Jude Children's
Research Hospital (SJCRH) and was treated with thoracic radiation for Hodgkin lymphoma

- Currently = 18 years of age

- = 5 years from original diagnosis

Exclusion Criteria (Hodgkin Lymphoma Survivor):

- History of cranial or total-body radiation therapy

- History of intrathecal Methotrexate, high-dose Methotrexate, or high-dose Cytarabine.

- History of head injury or diagnosis of a genetic disorder associated with
neurocognitive impairment

- History of a neurodevelopmental disorder or birth complication associated with
neurocognitive impairment

- History of congenital heart disease reported in the literature to be associated with
neurocognitive status as determined by the PIs

- Currently pregnant

- Secondary central nervous system (CNS) neoplasm

COMPARISON GROUP (CONTROL) ELIGIBILITY CRITERIA

Inclusion Criteria (Comparison Group):

- Research participant is a sibling, parent, relative or friend of a current or former
St. Jude patient

- Research participant must be at least 18 years of age at the time of the scheduled
evaluation

Exclusion Criteria (Comparison Group):

- History of cranial, total-body or thoracic radiation therapy

- History of intrathecal Methotrexate, high-dose Methotrexate, or high-dose Cytarabine.

- History of head injury or diagnosis of a genetic disorder associated with
neurocognitive impairment

- History of a neurodevelopmental disorder or birth complication associated with
neurocognitive impairment

- History of congenital heart disease reported in the literature to be associated with
neurocognitive status as determined by the PIs

- Currently pregnant

- History of cancer

- 1st degree relative of a survivor included in the current study.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03361020      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740